Previous close | 1.3850 |
Open | 1.3850 |
Bid | 1.3900 x 1594500 |
Ask | 1.4500 x 932700 |
Day's range | 1.3800 - 1.4050 |
52-week range | 0.6400 - 1.9850 |
Volume | |
Avg. volume | 154,578 |
Market cap | 230.415M |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0700 |
Earnings date | 27 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Some Race Oncology Limited ( ASX:RAC ) shareholders are probably rather concerned to see the share price fall 33% over...
Race Oncology Limited ("Race") is pleased to provide a strategic update, including an overview of revisions to corporate strategy, designed to optimise use of existing resources, while driving bisantrene's commercial partnering and collaboration potential.